Psychiatry and Clinical Neurosciences · 2009 · 65 citations · 25 references
MedicineNeurosciencePsychiatryNeuropsychiatryPsychiatric AssessmentPsychophysiologyAntipsychotic PharmacotherapyAntipsychotic TherapyAutonomic Nervous SystemAutonomic Nervous System FunctionMental IllnessSchizophrenia Spectrum DisordersAutonomic Function AssessmentAutonomic Nervous System AssessmentAutonomic Nervous System DysfunctionParasympathetic Nervous System ActivationParasympathetic Nervous System ActivityParasympathetic Nervous System DysfunctionParasympathetic Nervous System PhysiologyPsychotic Symptom Severity Scales
AIMS: Schizophrenia patients have a mortality rate two to three-fold higher than that of the general population. Despite the disorder's widespread recognition, how and to what extent autonomic nervous system (ANS) activity contributes to schizophrenia remains inconclusive. The aim of the present study, therefore, was to determine the extent of ANS activity depression with respect to healthy, well-matched control subjects and the severity of psychiatric disorders as determined using the Global Assessment of Functioning (GAF) scale among schizophrenia patients with special reference to antipsychotic dose. METHODS: This study included 71 schizophrenia patients and 72 healthy controls. ANS activity was assessed by means of heart rate variability power spectral analysis. RESULTS: ANS-related spectral parameters were three-four-fold lower in the patients compared to the control group (P < 0.01). Furthermore, when the patients without cardiovascular complications were classified according to GAF score, overall ANS (P = 0.033) and parasympathetic nervous system (PNS) activity (P = 0.025) were significantly reduced in the low-GAF as compared to the high-GAF group. Partial correlation analyses demonstrated that ANS activity was significantly correlated with GAF score while statistically eliminating the effects of age, gender, body mass index, antipsychotic dose, and lipid profiles of the patient population. CONCLUSION: The significantly lower ANS activity in the low-GAF group suggests that such autonomic functional depression could be associated with the severity of schizophrenia. The present data further imply that schizophrenia patients with more depressed overall ANS and PNS activity might encounter increasing risks for cardiovascular events such as sudden death.
25
Task Force of the European Society of Cardiology the North A Electrophysiology · Circulation · 1996 · 16.9K citations
Heart rate variability: Standards of measurement, physiological interpretation, and clinical use
Marek Malik, J. Thomas Bigger, A. John Camm et al. · European Heart Journal · 1996 · 15.3K citations · Full text
Nursing, Cardiology, Physiology +15
Mental Disorders and Use of Cardiovascular Procedures After Myocardial Infarction
Benjamin G. Druss · JAMA · 2000 · 542 citations
Medicine, Cardiology, Surgery +13